Unlike their Western competitors, the Chinese companies have not disclosed data from late-stage clinical trials that shows vaccine efficacy, and regulators in China have not officially approved them
A local resident receives a Sinovac's COVID-19 vaccine at a hospital on December 26, 2020 in Hefei, Anhui Province of China.
Image: VCG/VCG via Getty Images
©2019 New York Times News Service